Up Close and Personal with Deep Vein Thrombosis
- Wed, 9/3/08 - 10:25am
- 0 Comments
- 5560 reads
Clinicians often are so focused on their patients’ needs and symptoms they overlook their own health. If an elderly, hospitalized, or immobilized patient presented in a healthcare facility, clinicians would automatically check for deep venous thrombosis (DVT) but how frequently would an otherwise healthy, fairly young, busy medical professional acknowledge those symptoms and conduct self-screening? Typically, we are always on the go, giving up meals, exercise, or sleep when duty calls without a second thought. Sometimes, however, a second thought might help preserve our health so we can continue contributing to our patients’ well being. My personal experience with DVT underscores the need for clinicians to be aware and proactive about their own, as well as their patient’s, health.
Personal Experience
I was attending a conference on the West Coast, alternating sitting for extended times and walking long distances in high-heeled shoes. At some point during the conference, my left foot began to hurt. Walking became difficult but the discomfort could be endured. After the conference, I immediately went on a planned vacation. Two weeks after my vacation, I finally had my foot examined; the x-ray revealed a probable stress fracture. Naproxen and crutches eased the pain and my normal gait returned.
I did not have time to slow down — the back-to-back trips meant I had to tackle accumulated work, face looming deadlines, and assimilate the next batch of speaking materials before I left again to address another conference, barely 2 weeks later. During the conference, my foot and calf began to bother me. I awakened with leg cramps during the night. Thinking the pain and cramps were the result of too much walking, I elevated the leg more often.
When I returned to my office a few days later, my foot felt better but pain began to radiate into my knee and thigh. Soon, the calf became grossly swollen and hard. The back of the knee also was swollen and sore. I felt extreme pain in the leg almost instantaneously whenever my leg was not elevated. I called the nurse manager and my doctor; something was wrong.
A history was taken and clinical examination was followed by compression ultrasound that revealed thrombi occluding the saphenous and popliteal veins. Thankfully, I experienced no chest pain nor did the chest x-ray show any signs of pulmonary embolism. But I was stunned. Were my circumstances actually that conducive to DVT? I was traveling frequently (10 flights in 6 weeks), restricting my foot movement, and attending numerous conferences, but I am also a young mother with two preschoolers — wasn’t chasing them around enough to counteract periods of inactivity?
My doctor offered a choice: hospitalization or self-treatment as an outpatient with home health visits for venipuncture. Although outpatient treatment for DVT is not right for everyone, it helped me avoid potential nosocomial infections and maintain a sense of normalcy. I learned how to inject a low molecular weight heparin (LMWH), combining this blood-thinning regimen with oral warfarin. Until the pain medication took effect, I did not realize the extent of my discomfort. I had no choice but to slow down and comply with the imposed bedrest.
Trying to avoid the whiplash from the sudden change in pace was difficult at first but my body seemed to enjoy the new priority: rest. The forced down time allowed me to research DVT and related issues. I discovered why I had become vulnerable to the condition and decided to share my newfound knowledge with the hope that clinicians will be better able to recognize the risks and symptoms of DVT and, in turn, provide the appropriate timely care that can relieve the discomfort and the potential for complications.
1. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism: a statement for healthcare professionals. Circulation. 1996;93(12):2212–2245.
2. Bates SM, Ginsberg JS. Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351(3):268–277.
3. Deep vein thrombosis. Clinical Reference Systems: Adult Health Advisor. Windows Software. San Francisco, Calif: McKesson Health Solutions LLC;2004.
4. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet. 2005;365(9465):1163–1174.
5. Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med. 2001;344(20):1527–1535.
6. Markel A. Origin and natural history of deep vein thrombosis of the legs. Semin Vasc Med. 2005;5(1):65–74.
7. Simon DA, Dix FP, McCollum CN. Management of venous ulcers. BMJ. 2004;328: 1358–1362.
8. Shull KC, Nicolaides AN, Fernandes e Fernandea J, et al. Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg. 1979;114(11):1304–1306.
9. Standness Jr. DE, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA. 1983;250(10):1289–1292.
10. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334(11):677–681.
11. Gould MK, Dembitzer AD, Doyle RL, et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1999;130(10):800–809.
12. Spyropoulos AC, Hurley JS, Ciesla GN, et al. Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs. inpatient treatment with unfractionated heparin. Chest. 2002;122:108–114.
13. O’Brien B, Levine M, William A, et al. Economic evaluation of outpatient treatment with low-molecular weight heparin for proximal vein thrombosis. Arch Intern Med. 1999;159:2298–2304.
14. Bristol-Meyers Squibb Company. Coumadin (Warfarin sodium tablets, USP) Crystalline full prescribing information. Available at: http://www.coumadin.com/coumadin/home/hcp_index. Accessed October 20, 2005.
15. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thrombotic disease. Ann Intern Med. 1997;127(10):895–903.
16. Watson HG. Travel and thrombosis. Blood Rev. 2005;19(5):235–241.
17. Hsieh HF, Lee FP. Graduated compression stockings as prophylaxis for flight-related venous thrombosis: systemic literature review. J Adv Nurs. 2005;51(1):83–98.
18. Martinelli I, Taioli E, Battaglioli T, et al. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med. 2003;163(22):2771–2774.
19. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematol. 2005;2005:1–12.
20. Kemmermen JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ. 2001;323(7305):131–134.
21. Eckman MH, Singh SK, Erban JK, Kao G. Testing for Factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effective analysis. Med Decis Making. 2002;22(2):108–124.






Post new comment